Khoury, Rita http://orcid.org/0000-0003-2481-6816
Liu, Yu
Sheheryar, Quratulanne
Grossberg, George T. http://orcid.org/0000-0002-1493-3931
Article History
Accepted: 26 March 2021
First Online: 11 April 2021
Declarations
:
: No funding was received for the preparation of this article.
: Rita Khoury, Yu Liu, and Quratulanne Sheheryar have no conflicts of interest that are directly relevant to the content of this article. George T. Grossberg is a consultant for Acadia, Alkahest, Avanir, Axsome, Biogen, Bioxcel, Karuna, Lundbeck, Otsuka, Roche, and Takeda. He received research support from NIA, Janssen, and Roche, and is on the safety monitoring committee of Anavex, EryDel, Intra-Cellular Therapies, Merck, and Newron, and on the data monitoring committee of ITI Therapeutics.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: RK participated in the literature review, interpretation of data, and writing and revising the paper. YL and QS conducted the literature search and wrote the first draft of two sections of the paper. GG conceived the paper and critically reviewed its scientific content.